Ratings
0
Nobody has rated this yet. Be the first!
Works
7
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients
Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma.
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
